vs
Lyft, Inc.（LYFT）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Lyft, Inc.的季度营收约是Revvity的1.9倍（$1.5B vs $772.1M），Lyft, Inc.净利率更高（183.9% vs 12.7%，领先171.2%），Revvity同比增速更快（5.9% vs 3.6%），过去两年Lyft, Inc.的营收复合增速更高（11.3% vs 9.0%）
Lyft是美国仅次于优步的第二大网约车企业，在美国、加拿大提供网约车、电动滑板车及共享单车服务，还通过Free Now应用覆盖欧洲市场，目前拥有2500万活跃乘客，日均完成900万次出行订单。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
LYFT vs RVTY — 直观对比
营收规模更大
LYFT
是对方的1.9倍
$772.1M
营收增速更快
RVTY
高出2.3%
3.6%
净利率更高
LYFT
高出171.2%
12.7%
两年增速更快
LYFT
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $772.1M |
| 净利润 | $2.8B | $98.4M |
| 毛利率 | 35.1% | — |
| 营业利润率 | -12.4% | 14.5% |
| 净利率 | 183.9% | 12.7% |
| 营收同比 | 3.6% | 5.9% |
| 净利润同比 | 4363.0% | 3.9% |
| 每股收益（稀释后） | $6.59 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LYFTRVTY
| Q4 25 | $1.5B | $772.1M | ||
| Q3 25 | $1.5B | $698.9M | ||
| Q2 25 | $1.5B | $720.3M | ||
| Q1 25 | $1.4B | $664.8M | ||
| Q4 24 | $1.4B | $729.4M | ||
| Q3 24 | $1.4B | $684.0M | ||
| Q2 24 | $1.3B | $691.7M | ||
| Q1 24 | $1.2B | $649.9M |
净利润LYFTRVTY
| Q4 25 | $2.8B | $98.4M | ||
| Q3 25 | $46.1M | $46.7M | ||
| Q2 25 | $40.3M | $53.9M | ||
| Q1 25 | $2.6M | $42.2M | ||
| Q4 24 | $61.7M | $94.6M | ||
| Q3 24 | $-12.4M | $94.4M | ||
| Q2 24 | $5.0M | $55.4M | ||
| Q1 24 | $-31.5M | $26.0M |
毛利率LYFTRVTY
| Q4 25 | 35.1% | — | ||
| Q3 25 | 40.0% | 53.6% | ||
| Q2 25 | 36.7% | 54.5% | ||
| Q1 25 | 37.2% | 56.5% | ||
| Q4 24 | 39.5% | — | ||
| Q3 24 | 36.0% | 56.3% | ||
| Q2 24 | 38.0% | 55.7% | ||
| Q1 24 | 37.6% | 54.6% |
营业利润率LYFTRVTY
| Q4 25 | -12.4% | 14.5% | ||
| Q3 25 | 1.5% | 11.7% | ||
| Q2 25 | 0.2% | 12.6% | ||
| Q1 25 | -2.1% | 10.9% | ||
| Q4 24 | 1.9% | 16.3% | ||
| Q3 24 | -4.1% | 14.3% | ||
| Q2 24 | -2.1% | 12.4% | ||
| Q1 24 | -5.2% | 6.8% |
净利率LYFTRVTY
| Q4 25 | 183.9% | 12.7% | ||
| Q3 25 | 3.0% | 6.7% | ||
| Q2 25 | 2.7% | 7.5% | ||
| Q1 25 | 0.2% | 6.4% | ||
| Q4 24 | 4.3% | 13.0% | ||
| Q3 24 | -0.9% | 13.8% | ||
| Q2 24 | 0.4% | 8.0% | ||
| Q1 24 | -2.6% | 4.0% |
每股收益（稀释后）LYFTRVTY
| Q4 25 | $6.59 | $0.86 | ||
| Q3 25 | $0.11 | $0.40 | ||
| Q2 25 | $0.10 | $0.46 | ||
| Q1 25 | $0.01 | $0.35 | ||
| Q4 24 | $0.16 | $0.77 | ||
| Q3 24 | $-0.03 | $0.77 | ||
| Q2 24 | $0.01 | $0.45 | ||
| Q1 24 | $-0.08 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $919.9M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $3.3B | $7.3B |
| 总资产 | $9.0B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.32× | — |
8季度趋势，按日历期对齐
现金及短期投资LYFTRVTY
| Q4 25 | $1.8B | $919.9M | ||
| Q3 25 | $2.0B | $931.4M | ||
| Q2 25 | $1.8B | $991.8M | ||
| Q1 25 | $2.2B | $1.1B | ||
| Q4 24 | $2.0B | $1.2B | ||
| Q3 24 | $1.9B | $1.2B | ||
| Q2 24 | $1.8B | $2.0B | ||
| Q1 24 | $1.7B | $1.7B |
总债务LYFTRVTY
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $573.2M | — | ||
| Q1 25 | $979.9M | — | ||
| Q4 24 | $995.0M | — | ||
| Q3 24 | $1.0B | — | ||
| Q2 24 | $1.0B | — | ||
| Q1 24 | $971.5M | — |
股东权益LYFTRVTY
| Q4 25 | $3.3B | $7.3B | ||
| Q3 25 | $573.0M | $7.4B | ||
| Q2 25 | $732.7M | $7.6B | ||
| Q1 25 | $838.1M | $7.6B | ||
| Q4 24 | $767.0M | $7.7B | ||
| Q3 24 | $655.8M | $7.9B | ||
| Q2 24 | $577.6M | $7.9B | ||
| Q1 24 | $491.3M | $7.8B |
总资产LYFTRVTY
| Q4 25 | $9.0B | $12.2B | ||
| Q3 25 | $5.9B | $12.1B | ||
| Q2 25 | $5.4B | $12.4B | ||
| Q1 25 | $5.7B | $12.4B | ||
| Q4 24 | $5.4B | $12.4B | ||
| Q3 24 | $5.3B | $12.8B | ||
| Q2 24 | $5.0B | $13.4B | ||
| Q1 24 | $4.8B | $13.4B |
负债/权益比LYFTRVTY
| Q4 25 | 0.32× | — | ||
| Q3 25 | 1.85× | — | ||
| Q2 25 | 0.78× | — | ||
| Q1 25 | 1.17× | — | ||
| Q4 24 | 1.30× | — | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 1.74× | — | ||
| Q1 24 | 1.98× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $246.2M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 0.09× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流LYFTRVTY
| Q4 25 | $246.2M | $182.0M | ||
| Q3 25 | $291.3M | $138.5M | ||
| Q2 25 | $343.7M | $134.3M | ||
| Q1 25 | $287.2M | $128.2M | ||
| Q4 24 | $153.4M | $174.2M | ||
| Q3 24 | $264.0M | $147.9M | ||
| Q2 24 | $276.2M | $158.6M | ||
| Q1 24 | $156.2M | $147.6M |
自由现金流LYFTRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率LYFTRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度LYFTRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率LYFTRVTY
| Q4 25 | 0.09× | 1.85× | ||
| Q3 25 | 6.32× | 2.97× | ||
| Q2 25 | 8.53× | 2.49× | ||
| Q1 25 | 111.89× | 3.03× | ||
| Q4 24 | 2.48× | 1.84× | ||
| Q3 24 | — | 1.57× | ||
| Q2 24 | 55.09× | 2.87× | ||
| Q1 24 | — | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LYFT
暂无分部数据
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
